Neurobehavioral aspects of antioxidants in aging

International Journal of Developmental Neuroscience

Volumn 18, Issue 4-5, 2000, Pages 367-381

  Cantuti Castelvetri, Ippolita ^a   Shukitt Hale, Barbara ^a   Joseph, James A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIOXIDANT; ASCORBIC ACID; BIOFLAVONOID; FREE RADICAL; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; REACTIVE OXYGEN METABOLITE; SELEGILINE; THIOCTIC ACID;

AGING; ALPHA TOCOPHEROL DEFICIENCY; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; BEHAVIOR; DEGENERATIVE DISEASE; DEMENTIA; DIET; HUMAN; LIPID PEROXIDATION; LOCOMOTION; MEMORY; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; REVIEW; VEGETABLE;

EID: 0034237402     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(00)00008-3     Document Type: Article

References (162)

1. Ali M.M., Shukla G.S., Srivastava R.S., Mathur N., Chandra S.V. Effects of Vit. E on cadmium-induced locomotor dysfunctions in rats. Vet. Hum. Toxicol. 35:1993;109-111.
2. Allain H., Raoul P., Lieury A., LeCoz F., Gandon J.-M. Effect of two doses of Ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. Clin. Therap. 15:1993;549-558.
3. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA. 90:1993;7915-7922.
4. Armstrong B.K., Mann J.I., Adelstein A.M., Eskin F. Commodity consumption and ischemic heart disease mortality, with special reference to dietary practices. J. Chron. Dis. 28:1975;455-469.
5. Artur Y., Herbeth B., Guemouri L., Lecomte E., Jeandel C., Siest G. Age-related variations of enzymatic defenses against free radicals and peroxides. EXS. 62:1992;359-367.
6. Behl C., Davis J., Cole G.M., Schubert D. Vitimin E protects nerve cells from amyloid β protein toxicity. Biochem. Res. Comm. 186:1992;944-950.
7. Benzi G., Moretti A. Are reactive oxygen species involved in Alzheimer's Disease? Neurobiol. Aging. 16:1995;661-674.
8. Biewenga G.P., Haenen G.R.M.M., Bast A. The pharmacology of the antioxidant Lipoic acid. Gen. Pharmac. 29:1997;315-331.
9. Birkmayer W., Knoll J., Riederer P., Youdim M.B. (-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease. Mod. Probl. Pharmacopsychiatry. 19:1983;170-176.
10. Birkmayer W., Knoll J., Riederer P., Youdim M.B., Hars V., Marton J. Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's Disease: a longterm study. J. Neural Transm. 64:1985;113-127.
11. Bors W., Heller W., Michel C., Stettmaier K. Flavonoids and polyphenols: chemistry and biology. Cadenas E., Packer L. Handbook of Antioxidants. 1996;409-466 Marcel Dekker Inc, New York.
12. Brailowsky S., Montiel T. Motor Function in young and aged hemiplegic rats: effects of a Ginkgo biloba extract. Neurobiol. Aging. 18:1997;219-227.
13. Burton G.W., Ingold K.U. Vitimin E as an in vitro and in vivo antioxidant. Ann. N.Y. Acad. Sci. 570:1989;7-22.
14. Butterfield D.A., Koppal T., Subramaniam R., Hall N., Hensley K., Yatin S., Allen K., Aksenov M., Aksenova M., Carney J. Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tert-butyl-alpha-phenylnitrone and vitimin E. Ann. N.Y. Acad. Sci. 854:1998;448-462.
15. Buzina-Suboticanec K., Buzina R., Stavljenic A., Farley T.M., Haller J., Bergman-Markovic B., Gorajscan M. Ageing, nutritional status and immune response. Int. J. Vitam. Nutr. Res. 68:1998;133-141.
16. Cadenas E., Packer L. Handbook of Antioxidants. 1996;Marcel Dekker Inc, New York.
17. Cadet J.L. The potential use of vitimin E and selenium in parkinsonism. Med. Hypotheses. 20:1986;87-94.
18. Cadet J.L., Brannok C. Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int. 32:1998;117-131.
19. Cadet J.L., Katz M., Jackson-Lewis V., Fahn S. Vitimin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence. Brain Res. 476:1989;10-15.
20. Cao X., Phillis J.W. The free radical scavenger, α-lipoic acid, protects against cerebral ischemia-reperfusion injury in gerbils. Free Rad. Res. 23:1995;365-370.
21. Cohen G., Hekkila R.E. The generation of hydrogen-peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J. Biol. Chem. 249:1974;2447-2452.
22. Denisova N.A., Tsaioun K., Bielinski D., Palmer H., Paulson E., Joseph J.A. Age-related and area-specific regulation of mitogen-activated protein kinases by oxidative stress in synaptosomes. FASEB J. 12:1998;A1844.
23. deRijk M.C., Breteler M.M.B., denbreeijen J.H., Launer L.J., Grobbee D.E., van der Meché F.G.A., Hofman A. Dietary antioxidants and Parkinson Disease. The Rotterdam study. Arch. Neurol. 54:1997;762-765.
24. Dexter D.T., Jenner P., Shapira A.H.V., Mardsen C.D. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative disease affecting the basal ganglia. Ann. Neurol. 32:1992;S94-S100.
25. Doll R. Lifestyle: an overview. Cancer Detect Prevent. 14:1990;589-594.
26. Dreosti I.E. Nutrition, cancer, and aging. Ann. N.Y. Acad. Sci. 854:1998;371-377.
27. Drewnowski A., Rock C.L., Henderson S.A., Shore A.B., Fischler C., Galan P., Preziosi P., Hercberg S. Serum beta-carotene and vitamin C as biomarkers of vegetable and fruit intakes in a community-based sample of French adults. Am. J. Clin. Nutr. 65:1997;1796-1802.
28. Drieu K. Préparation et définition de l'extrait de Ginkgo biloba. Presse Med. 15:1986;1455-1457.
29. Dubey A., Forster M.J., Sohal R.S. Effect of the spin-trapping compound n-tert-butyl-phenylnitrone on protein oxidation and life span. Arch. Biochem. Biophys. 324:1995;249-254.
30. Erin A.N., Spirin M.M., Tabidze L.V., Kagan V.E. Formation of α-tocopherol complexes with fatty acids. A hypothetical Mechanism of Stabilization of Biomembranes by vitimin E. Biochim. Biophys. Acta. 774:1984;96-102.
31. Fahn S. A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease. Ann. Neurol. 32:1992;S128-S132.
32. Fahn S. An open trial of high-dosage antioxidants in early Parkinson's disease. Am. J. Clin. Nutr. 53:1991;380S-382S.
33. Fariello R.G. Biochemical profile of vulnerable neurons in neurodegenerative disorders. Intl J. Tissue React. 12:1990;179-181.
34. Farrel P.M., Roberts R.J. Vitimin E. Shils M.E., Olson J.A., Shike M. Modern Nutrition in Health and Disease. 1994;326-341 Lea and Febiger, Philadelphia, PA.
35. Ferro-Luzi A., Branca F. Mediterranean diet, Italian-style: prototype of a healthy diet. Am. J. Clin. Nutr. 61:1995;1338S-1345S.
36. Formica J.V., Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxic. 33:1995;1061-1080.
37. Freund G. The effect of chronic alcohol and vitimin E consumption on aging pigments and learning performance. Life Sci. 24:1979;145-152.
38. Golbe L.I., Farrel T.M., Davis P.H. Case-control study of early life dietary factors in Parkinson's disease. Arch. Neurol. 45:1988;1350-1353.
39. Golbe L.I., Farrel T.M., Davis P.H. Follow-up study of early-life protective and risk factors in Parkinson's disease. Movement Disord. 5:1990;66-70.
40. Goodwin J.S., Brodwick M. Diet, aging and cancer. Clin. Geriatr. Med. 11:1995;577-589.
41. Götz M.E., Dirr A., Burger R., Janetzky B., Weinmüller M., Chan W.W., Chen S.C., Reichmann H., Rausch W.-D., Riederer P. Effect of Lipoic acid on redox state of coenzyme Q in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate. Eur. J. Pharmacol. 266:1994;291-300.
42. Grimble R.F. Effect of antioxidative vitamins on immune function with clinical applications. Intl. J. Vitam. Nutr. Res. 67:1997;312-320.
43. Gsell W., Conrad R., Hickthier M., Sofic E., Frölich L., Wichart I., Jellinger K., Moll G., Ransayr G., Beckmann H., Riederer P. Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer Type. J. Neurochem. 64:1995;1216-1223.
44. Halder J., Bhaduri A.N. Protective role of black tea against oxidative damage of human red blood cells. Biochem. Biophys. Res. Comm. 244:1998;903-907.
45. Hara H., Kato H., Kogure K. Protective effect of α-tocopherol on ischemic neuronal damage in the gerbil hippocampus. Brain Res. 510:1990;335-338.
46. Haramaki N., Packer L., Assadnazari H., Zimmer G. Cardiac recovery during post-ischemic reperfusion is improved by combination of vitimin E with dihydrolipoic acid. Biochem. Biophys. Res. Commun. 196:1993;1101-1107.
47. Harding A.E. Vitimin E and the nervous system. CRC Crit. Rev. Neurobiol. 3:1987;89-103.
48. Harding A.E., Matthews S., Jones S., Ellis C.J.K., Booth I.W., Muller D.P.R. Spinocerebellar degeneration associated with a selective defect of vitimin E absorption. New Engl. J. Med. 313:1985;32-35.
49. Harman D. Free-radical theory of aging. Increasing the functional life span. Ann. N.Y. Acad. Sci. 717:1994;1-15.
50. Hauser R.A., Zesiewicz T.A. Parkinson's Disease. Questions and Answers. 1996;Merit Publ. Intl, Coral Springs, FL.
51. Hellenbrand W., Boeing H., Robra B.P., Seidler A., Vieregge P., Nischan P., Joerg J., Oertel W.H., Schneider E., Ulm G. Diet and Parkinson's Disease II: a possible role for the past intake of specific nutrients. Neurol. 47:1996;644-650.
52. Hughes K. Diet and coronary heart disease - a review. Ann. Acad. Med. Singapore. 24:1995;224-229.
53. Ichitani Y., Okaichi H., Yoshikawa T., Ibata Y. Learning behaviour in chronic vitimin E-deficient and-supplemented rats: radial arm maze learning and passive avoidance response. Behav. Brain Res. 51:1992;157-164.
54. Johnson, K. and Kligman, E. W., Preventive nutrition: disease-specific dietary interventions for older adults. Geriatrics, 1992, 47, 39-40, 45-49.
55. Joseph J.A., Denisova N., Fisher D., Shukitt-Hale B., Bickford P., Prior R., Cao G. Age-related neurodegeneration and oxidative stress: Putative nutritional intervention. Neurologic Clinics of North America: The Neurology of Aging. 16:1998;747-755.
56. Joseph J. A., Shukitt-Hale B., Denisova N. A., Bielinski D., Martin A. and Bickford P. C., Reversal of age-related declines in neuronal signal transduction, cognitive and motor behavioral deficits with diets supplemented with fruit or vegetable extracts high in antioxidant activity. J. Neurosci., 1999, 19, 8114-8121.
57. Joseph J.A., Shukitt-Hale B., Denisova N.A., Prior R.L., Cao G., Martin A., Taglialatela G., Bickford P.C. Long-term dietary strawberry, spinach, or vitimin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J. Neurosci. 18:1998;8047-8055.
58. Joseph J.A., Strain J.G., Jimenez N.D., Fisher D. Oxidant injury in PC12 cells - a possible model of calcium "deregulation" in aging. I. Selectivity of protection against oxidative stress. J. Neurochem. 69:1997;1252-1258.
59. +-evoked dopamine release from striatal slices by cholesterol and S-adenosyl-L-Methionine. Brain Res. 673:1995;185-193.
60. Kalmijn S., Feskens E.J.M., Launer L.J., Kromhout D. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am. J. Epidemiol. 145:1997;33-41.
61. Kanowski S., Herrmann W.M., Stephan K., Wierich W., Hörr R. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiat. 29:1996;47-56.
62. Kieburtz K., McDermott M., Como P., Growdon J., Brady J., Carter J., Huber S., Kanigan B., Landow E., Rudolph A., Saint-Cyr J., Stern Y., Tennis M., Thelen J., Shoulson I., The Parkinson Study Group. The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Neurol. 44:1994;1756-1759.
63. Kilander L., Öhrvall M. Alpha-tocopherol and Alzheimer's Disease. New Engl. J. Med. 337:1997;572.
64. Krischer S.M., Eisemann M., Bock A., Mueller M.J. Protein-facilitated export of arachidonic acid from pig neutrophils. J. Biol. Chem. 272:1997;10601-10607.
65. La Rue A., Koehler K.M., Wayne S.J., Chiulli S.J., Haaland K.Y., Garry P.J. Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am. J. Clin. Nutr. 65:1997;20-29.
66. Lal H., Pogacar S., Daly P.R., Puri S.K. Behavioral and neuropathological manifestations of nutritionally induced central nervous system "aging" in the rat. Prog. Brain Res. 40:1973;129-140.
67. 2+. Ann. N.Y. Acad. Sci. 746:1994;308-321.
68. Landvik S.V., Diplock A.T., Packer L. Efficacy of vitimin E in human health and disease. Cadenas E., Packer L. Handbook of Antioxidants. 1996;63-87 Marcel Dekker Inc, New York.
69. Langston J.W. The etiology of Parkinson's disease with emphasis on the MPTP story. Neurology. 47:(6 suppl 3):1996;S153-S160.
70. Langston J.W. Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate. Ann. Neurol. 44:1998;S45-S52.
71. Launer L.J., Kalmijn S. Anti-oxidants and cognitive function: a review of clinical and epidemiological studies. J. Neural. Transm. Suppl. 53:1998;1-8.
72. LeBars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.N., Schatzberg A.F. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA. 278:1997;1327-1332.
73. LePoncin Lafitte M., Rapin J., Rapin J.R. Effects of Ginkgo biloba on changes induced by quantitative cerebral microembolization in rats. Arch. Int. Pharmacodyn. 243:1980;236-244.
74. Letan A. Studies of the possible transference of flavonol antioxidants from the diet to the tissue lipids of rats. Brit. J. Nutr. 21:1967;315-323.
75. Logroscino G., Marder K., Cote L., Tang M.-X., Shea S., Mayeux R. Dietary lipids and antioxidants in Parkinson's Disease: a population-based, case-control study. Ann. Neurol. 39:1996;89-94.
76. Losonczy K.G., Harris T.B., Havlik R.J. Vitimin E and vitamin C supplement use and risk of all-cause and coronay heart disease mortality in older persons: the established populations for epidemiologic studies of the elderly. Am. J. Clin. Nutr. 64:1996;190-196.
77. Lynch M.A. Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukien-1 beta? Progr. Neurobiol. 56:1998;571-589.
78. Mason R.P., Leeds P.R., Jacob R.F., Hough C.J., Zhang K.G., Mason P.E., Chuang D.M. Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells. J. Neurochem. 72:1999;1448-1456.
79. Maurer K., Ihl R., Dierks T., Frölich L. Clinical Efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J. Psychiat. Res. 31:1997;645-655.
80. Mayne S.T. Beta-carotene, carotenoids and disease prevention in humans. FASEB J. 10:1996;690-701.
81. McCann S.M., Licinio J., Wong M.L., Karanth S., Rettorri V. The nitric oxide hypothesis of aging. Exp. Gerontol. 33:1998;812-826.
82. McCarron M.O., Russel A.J., Metcalfe R.A., Deysilva R. Chronic vitimin E deficiency causing spinocerebellar degeneration, peripheral neuropathy, and centro-cecal scotomata. Nutrition. 15:1999;217-219.
83. McNaught K.S., Carrupt P.A., Altomare C., Cellamare S., Carotti A., Testa B., Jenner P., Mardsen C.D. Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease. Biochem. Pharmacol. 56:1998;921-933.
84. Meydani S.N., Beharka A.A. Recent developments in vitimin E and immune response. Nutr. Rev. 56:1998;S49-S58.
85. Meydani S.N., Meydani M., Blumberg J.B., Leka L.S., Siber G., Loszewski R., Thompson C., Pedrosa M.C., Diamond R.D., Stollar B.D. Vitimin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA. 277:1997;1380-1386.
86. Mirzoeva O.K., Calder P.C. The effect of propolis and its components on eicosanoid production during the inflammatory response. Prostag. Leuk. Essent. Fatty Acids. 55:1996;441-449.
87. Mitra S.K., Chakraborti A., Bhattacharya S.K. Neuropharmacological studies on Panax ginseng. Ind. J. Exp. Biol. 34:1996;41-47.
88. Moriguchi T., Saito H., Nishiyama N. Anti-ageing effect of aged garlic extract in the inbred brain atrophy mouse model. Clin. Exp. Pharm. Physiol. 24:1997;235-242.
89. Moriguchi T., Takashina K., Chu P.-J., Saito H., Nishiyama N. Prolongation of life span and improved learning in the senescence accelerated mouse produced by aged garlic extract. Biol. Pharm. Bull. 17:1994;1589-1594.
90. Muller D.P.R., Lloyd J.K., Wolff O.H. Vitimin E and neurological function. Lancet. 1:1983;225-228.
91. Müller U., Krieglstein J. Prolonged treatment with α-lipoic acid protects cultured neurons against hypoxic, glutamate-, or iron-induced injury. J. Cereb. Blood Flow Metab. 15:1995;624-630.
92. Nishiyama N., Chu P.-J., Saito H. An herbal prescription, S-113 m, consisting of biota, ginseng and schizandra, improves learning performance in senescence accelerated mouse. Biol. Pharm. Bull. 19:1996;388-393.
93. Nishiyama N., Zhou Y., Saito H. Ameliorative effects of chronic treatment using DX-9386, a traditional Chinese prescription, on learning performance and lipid peroxide content in senescence accelerated mouse. Biol. Pharm. Bull. 17:1994;1481-1484.
94. Oberpichler H., Beck T., Abdel-Raman M.M., Bielenberg G.W., Krieglstein J. Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. Pharm. Res. Comm. 20:1988;349-368.
95. O'Donnel E., Lynch M.A. Dietary antioxidant supplementation reverses age-related neuronal changes. Neurobiol. Aging. 19:1998;461-467.
96. Omenn G.S. Micronutrients (vitamins and minerals) as cancer-preventive agents. IARC Sci. Publ. 139:1996;33-45.
97. Orrenius S., McConkey D.J., Nicotera P. Role of calcium in toxic and programmed cell death. Adv. Exp. Med. Biol. 283:1991;419-425.
98. Oyama Y., Chikahisa L., Ueha T., Kanemaru K., Noda K. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res. 712:1996;349-352.
99. Packer L. α-Lipoic acid: a metabolic antioxidant which regulates NF-κB signal transduction and protects against oxidative injury. Drugs Metab. Rev. 30:1998;245-275.
100. Packer L., Landvik S. Vitimin E: introduction to biochemistry and health benefits. Ann. N.Y. Acad. Sci. 570:1989;1-6.
101. Packer L., Witt E.H., Tritschler H.J. Antioxidant properties and clinical applications of alpha-lipoic acid and dihydrolipoic acid. Cadenas E., Packer L. Handbook of Antioxidants. 1996;545-591 Marcel Dekker Inc, New York.
102. Paniraghi M., Sadguna Y., Shivakumar B.R., Kolluri S.V.R., Roy S., Packer L., Ravindranath V. α-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats. Brain Res. 717:1996;184-188.
103. Paolisso G., Gambarella A., Giuliano D., Galzerano D., Amato L., Volpe C., Balbi V., Varricchio M., D'onofrio F. Chronic intake of pharmacological doses of vitamin E might be useful in the therapy of elderly patients with coronary heart disease. Am. J. Clin. Nutr. 61:1995;848-852.
104. Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson's Disease. New Eng. J. Med. 321:1989;1364-1371.
105. Parkinson Study Group. Effect of tocopherol and deprenyl on the progression of disability in early Parkinson's Disease. The Parkinson's Study Group. New Engl. J. Med. 328:1993;176-183.
106. Parkinson Study Group. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Ann. Neurol. 39:1996;37-45.
107. Parkinson Study Group. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients not requiring levodopa. Ann. Neurol. 39:1996;29-36.
108. Parkinson's Study Group. Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Ann. Neurol. 43:1998;318-325.
109. Perrig W.J., Perrig P., Stähelin H.B. The relation between antioxidants and memory performance in the old and very old. J. Am. Geriatr. Soc. 45:1997;718-724.
110. Petkov V.D., Kehayov R., Belcheva S., Konstantinova E., Petkov V.V., Getova D., Markovska V. Memory effects of standardized extracts of Panax ginseng (G115), Ginkgo biloba (GK 501) and their combination Gincosan® (PHL-00701). Planta Med. 59:1993;106-114.
111. Pincus M.M. Alpha-tocopherol and Alzheimer's Disease. New Engl. J. Med. 337:1997;572.
112. Pinto J.T., Qiao C., Xing J., Rivilin R.S., Protomastro M.L., Weissler M.L., Tao Y., Thaler H., Heston W.D. The effects of garlic thioallyl dervitaives on growth glutathione concentration and polyamine formation of human prostate carcinoma cells in culture. Am. J. Clin. Nutr. 66:1997;398-405.
113. Pitchumoni S.S., Doraiswamy P.M. Current Status of antioxidant therapy for Alzheimer's Disease. J. Am. Geriatr. Soc. 46:1998;1566-1572.
114. Podda M., Tritscler H.J., Ulrich H., Packer L. α-Lipoic acid supplementation prevents symptoms of vitimin E deficiency. Biochem. Biophys. Res. Comm. 204:1994;98-104.
115. Poirier J., Thiffault C. Are free radicals involved in the pathogenesis of idiopathic Parkinson's Disease? Eur. Neurol. 33:(suppl):1993;38-43.
116. Pollack A.E., Turgeon S.M., Fink J.S. Apomorphine priming alters the response of striatal outflow pathways to D-2 agonist stimulation in 6-hydroxydopamine lesioned rats. Neurosci. 79:1997;79-93.
117. Porsolt R.D., Martin P., Lenègre A., Fromage S., Drieu K. Effects of an extract of Ginkgo biloba (EGb 761) on "learned helplessness" and other models of stress in rodents. Pharmacol. Biochem. Behav. 36:1990;963-971.
118. Ramassamy C., Clostre F., Christen Y., Costentin J. Prevention by Ginkgo biloba extract (GBE 761) of the dopaminergic neurotoxicity of MPTP. J. Pharm. Pharmacol. 42:1990;785-789.
119. 2+-induced decrease in synaptosomal membrane fluidity. Free Rad. Res. Comm. 19:1993;341-350.
120. Reed L.J. Multienzyme complex. Acc. Chem. Res. 7:1974;40-46.
121. Reiter R.J., Guerrero J.M., Garcia J.J., Acuna-Castroviejo D. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin. Ann. N.Y. Acad. Sci. 854:1998;410-424.
122. Rosenberg R., Culik R. Effect of α-lipoic acid on vitamin C and Vitimin E deficiencies. Arch. Biochem. Biophys. 80:1959;86-93.
123. Sakai S., Moriguchi S. Long-term feeding of high vitimin E diet improves the decreased mitogen response of rat splenic lymphocytes with ageing. J. Nutr. Sci. Vitaminol. 43:1997;113-122.
124. Sano M., Ernesto C., Klauber M.R., Schafer K., Woodbury P., Thomas R., Grundman M., Growdon J., Thal L.J., et al. Rationale and design of a multicenter study of selegiline and α-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer Dis. Assoc. Dis. 10:1996;132-140.
125. Sano M., Ernesto C., Thomas R., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's Disease. New Engl. J. Med. 336:1997;1216-1222.
126. Sarter M., van der Linde A. Vitimin E deprivation in rats: some behavioral and histochemical observations. Neurobiol. Aging. 8:1987;297-307.
127. Satya-Murti S., Howard L., Krohel G., Wolf B. The spectrum of neurologic disorder from vitimin E deficiency. Neurol. 36:1986;917-921.
128. Scheider W.L., Hershey L.A., Vena J.E., Holmund T., Marshall J.R., Freundenheim J.L. Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease. Movement Disord. 12:1997;190-196.
129. Serbinova E., Khwaja S., Reznick A.Z., Packer L. Thioctic acid protects against ischemia-reperfusion injury in the isolated perfused Langendorff heart. Free Rad. Res. Commun. 17:1992;49-58.
130. Sharoni Y., Giron E., Rise M., Levy J. Effects of lycopene-enriched tomato oleoresin on 7,12-dimethyl-benz[a]anthracene-induced rat mammary tumors. Cancer Detect Prevent. 21:1997;118-123.
131. Shigenaga M.K., Ames B.N. Assays for 8-hydroxy-2′-deoxyguanosine: a biomarker of in vivo oxidative DNA damage. Free Rad. Biol. Med. 10:1991;211-216.
132. Sinatra S.T., DeMarco J. Free radicals, Oxidative stress, oxidized low density lipoprotein (LDL), and the heart: antioxidants and other strategies to limit cardiovascular damage. Conn. Med. 59:1995;579-588.
133. Smith C.D., Carney J.M., Starke-Reed P.E. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's diseases. Proc. Natl. Acad. Sci. USA. 88:1991;10540-10543.
134. Sofic E., Lange K.W., Jellinger K., Riederer P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's Disease. Neurosci. Lett. 142:1992;128-130.
135. Sofic E., Riederes P., Heinsen H., Beckman H., Reynolds G.P., Hebenstreit G., Youdim M.B.H. Increased iron (III) and total iron content in post mortem substantia nigra of Parkinsonian brain. J. Neural. Transm. 74:1988;199-205.
136. Sokol R.J., Butler-Simon N., Heubi J.E., Iannaccone S.T., McClung H.J., Accurso F., Hammond K., Heyman M., Sinatra F., Riely C., Perrault J., Levy J., Silverman A. Vitimin E deficiency neuropathy in children with fat malabsorption. Studies in cystic fibrosis and chronic cholestasis. Ann. N.Y. Acad. Sci. 570:1989;156-169.
137. Sokol R.J. Vitimin E and neurologic function in man. Free Rad. Biol. Med. 6:1989;189-207.
138. Sokol R.J. Vitimin E deficiency and neurologic disease. Ann. Rev. Nutr. 8:1988;351-373.
139. Sokol R.J., Kayden H.J., Bettis D.B., Traber M.G., Neville H., Ringel S., Wilson W.B., Stumpf D.A. Isolated vitimin E deficiency in the absence of fat malabsorption- familial and sporadic cases: characterization and investigation of causes. J. Lab. Clin. Med. 111:1988;548-559.
140. Šrám R.J., Binková B., Topinka J., Kotěšovec F., Fojtíková I., Hanel I., Klaschka J., Kočišová J., Prošek M., Machálek J. Effect of antioxidant supplementation in an elderly population. Basic Life Sci. 61:1993;459-477.
141. Stocker R., Bowry V.W. Tocopherol-mediated peroxidation of lipoprotein lipids and its inhibition by co-antioxidants. Cadenas E., Packer L. Handbook of Antioxidants. 1996;27-41 Marcel Dekker Inc, New York.
142. Stoll S., Hartmann H., Cohen S.A., Müller W.E. The potent free radical scavenger α-lipoic acid improves memory in aged mice: putative relationship to NMDA receptor deficits. Pharmacol. Biochem. Behav. 46:1993;799-805.
143. Stoll S., Rostock A., Bartsch R., Korn E., Meichelböck A., Müller W.E. The potent free radical scavenger α-lipoic acid improves cognition in rodents. Ann. N.Y. Acad. Sci. 717:1994;122-128.
144. Stoll S., Scheuer K., Pohl O., Müller W.E. Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse. Pharmacopsychiat. 29:1996;144-149.
145. Subramaniam R., Koppal T., Green M., Yatin S., Jordan B., Drake J., Butterfield D.A. The free radical antioxidant vitimin E protects cortical synaptosomal membranes from amyloid beta-peptide (23-35) toxicity but not from hydroxynonenal toxicity: relelvance to the free radical hypothesis of Alzheimer's disease. Neurochem. Res. 23:1998;1403-1410.
146. Summerfield F.W., Tappel A.L. Effects of dietary polyunsaturated fats and vitimin E on aging and peroxidative damage to DNA. Arch. Biochem. Biophys. 233:1984;408-416.
147. Thomas S.R., Neuzil J., Stocker R. Coantioxidants make α-tocopherol an efficient antioxidant for low-density lipoprotein. Am. J. Clin. Nutr. 62:1995;1357S-1364S.
148. Thurman J.E., Mooradian A.D. Vitamin supplementation therapy in the elderly. Drugs Aging. 11:1997;433-449.
149. van Reekum R., Simard M., Farcnik K. Diagnosis of dementia and treatment of Alzheimer's disease. Pharmacologic managment of disease progression and cognitive impairment. Can. Fam. Physician. 45:1999;945-952.
150. Verlangieri A.J., Kapeghian J.C., el-Dean S., Bush M. Fruit and vegetable consumption and cardiovascular mortality. Med. Hypothesis. 16:1985;7-15.
151. Wagner B.A., Buettner G.R., Burns P. Vitimin E slows the rate of free radical-mediated lipid peroxidation in cells. Arch. Biochem. Biophys. 334:1996;261-267.
152. Wander R.C., Hall J.A., Gradin J.L., Du S.H., Jewell D.E. The ratio of dietary (n-6) to (n-3) fatty acids influences immune system function, eicosanoid metabolism, lipid peroxidation and vitimin E status in aged dogs. J. Nutr. 127:1997;1198-1205.
153. Wang H. and Joseph J. A., Structure-activity relationships of quercetin in antagonizing hydrogen peroxide-induced calcium dysregulation in PC12 cells. Free Rad. Biol. Med., 1999, 27, 683-694.
154. Warasama Jama J., Launer L.J., Witteman J.C.M., denbreeijen J.H., Breteler M.M.B., Grobbee D.E., Hofman A. Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam study. Am. J. Epidemiol. 144:1996;275-280.
155. Ward J. Free radicals, antioxidants and preventive geriatrics. Aust. Fam. Physician. 23:1994;1297-1301.
156. Wattenberg L.W., Coccia J.B. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone carcinogenesis in mice by D-limonene and citrus fruit oils. Carcinogenis. 12:1991;115-117.
157. Willett W.C. Diet and health: what should we eat? Science. 264:1994;532-537.
158. Willett W.C. Micronutrients and cancer risk. Am. J. Clin. Nutr. 59:1994;1162S-1165S.
159. Winter J.C. The effect of an extract of Ginkgo biloba, EGb 761, on cognitive behavior and longevity in the rat. Physiol. Behav. 63:1998;425-433.
160. Wolozin B., Luo Y., Wood K. Neuronal loss in aging and disease. Holbrook N.J., Martin G.R., Locksmith R.A. Cellular Aging and Cell Death. 1996;283-302 Wiley-Liss, New York.
161. Wolz P., Krieglstein J. Neuroprotective effects of α-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia. Neuropharm. 35:1996;369-375.
162. Yamamoto M., Shima T., Uozumi T., Sogabe T., Yamada K., Kawasaki T. A possible role of lipid peroxidation in cellular damage caused by ischemia and the protective effect of α-tocopherol administration. Stroke. 14:1983;977-982.